Kalnins U - Search Results

1

Comparison of early and late results of a Carbofilm-coated stent versus a pure high-grade stainless steel stent (the Carbostent-Trial).

Sick PB, Gelbrich G, Kalnins U, Erglis A, Bonan R, Aengevaeren W, Elsner D, Lauer B, Woinke M, Brosteanu O, Schuler G. Sick PB, et al. Among authors: kalnins u. Am J Cardiol. 2004 Jun 1;93(11):1351-6, A5. doi: 10.1016/j.amjcard.2004.02.029. Am J Cardiol. 2004. PMID: 15165913 Clinical Trial.

2

Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients.

Haude M, Konorza TF, Kalnins U, Erglis A, Saunamäki K, Glogar HD, Grube E, Gil R, Serra A, Richardt HG, Sick P, Erbel R; Heparin-COAted STents in small coronary arteries Trial Investigators. Haude M, et al. Among authors: kalnins u. Circulation. 2003 Mar 11;107(9):1265-70. doi: 10.1161/01.cir.0000053442.64637.34. Circulation. 2003. PMID: 12628946 Clinical Trial.

3

Clinical outcomes of silicon carbide coated stents in patients with coronary artery disease.

Kalnins U, Erglis A, Dinne I, Kumsars I, Jegere S. Kalnins U, et al. Med Sci Monit. 2002 Feb;8(2):PI16-20. Med Sci Monit. 2002. PMID: 11859292

4

Prognostic value of tryptophan load test followed by serum kynurenine determination. Its comparison with pyridoxal-5-phosphate, kynurenine, homocysteine and neopterin amounts.

Rudzite V, Fuchs D, Kalnins U, Jurika E, Silava A, Erglis A, Trusinskis K, Jegere S. Rudzite V, et al. Among authors: kalnins u. Adv Exp Med Biol. 2003;527:307-15. doi: 10.1007/978-1-4615-0135-0_34. Adv Exp Med Biol. 2003. PMID: 15206744

5

[Interventional cardiology in Latvia from 1993 to 2003].

Kalnins U, Erglis A, Rudzitis A, Schneider M, Köhler F. Kalnins U, et al. Dtsch Med Wochenschr. 2004 Apr 30;129 Suppl 1:S29-32. doi: 10.1055/s-2004-824841. Dtsch Med Wochenschr. 2004. PMID: 15133740 Review. German.

6

Nitric oxide production and arachidonic acid metabolism in platelet membranes of coronary heart disease patients with and without diabetes.

Tretjakovs P, Kalnins U, Dabina I, Erglis A, Dinne I, Jurka A, Latkovskis G, Zvaigzne A, Pirags V. Tretjakovs P, et al. Among authors: kalnins u. Med Princ Pract. 2003 Jan-Mar;12(1):10-6. doi: 10.1159/000068154. Med Princ Pract. 2003. PMID: 12566962 Free article.

7

Plasma HDL-cholesterol has an effect on nitric oxide production and arachidonic acid metabolism in the platelet membranes of coronary heart disease patients without LDL-hypercholesterolemia.

Tretjakovs P, Kalnins U, Dabina I, Dinne I, Erglis A, Kumsars I, Jurka A. Tretjakovs P, et al. Among authors: kalnins u. Med Sci Monit. 2000 May-Jun;6(3):507-11. Med Sci Monit. 2000. PMID: 11208362

8

Immune activation and degradation of tryptophan in coronary heart disease.

Wirleitner B, Rudzite V, Neurauter G, Murr C, Kalnins U, Erglis A, Trusinskis K, Fuchs D. Wirleitner B, et al. Among authors: kalnins u. Eur J Clin Invest. 2003 Jul;33(7):550-4. doi: 10.1046/j.1365-2362.2003.01186.x. Eur J Clin Invest. 2003. PMID: 12814390

9

[The health care system in the republic of Latvia].

Rudzitis A, Kalnins U, Köhler F, Rudzitis A. Rudzitis A, et al. Among authors: kalnins u. Dtsch Med Wochenschr. 2004 Apr 30;129 Suppl 1:S11-2. doi: 10.1055/s-2004-824845. Dtsch Med Wochenschr. 2004. PMID: 15133735 German. No abstract available.

10

C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease.

Latkovskis G, Licis N, Kalnins U. Latkovskis G, et al. Among authors: kalnins u. Eur J Immunogenet. 2004 Oct;31(5):207-13. doi: 10.1111/j.1365-2370.2004.00476.x. Eur J Immunogenet. 2004. PMID: 15379752

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page